Summary
Introduction
Glandular kallikreins (EC 3.4.21.8) are present in exocrine organs and their secretions as well as in the kidney and urine. The amounts of urinary kallikrein are decreased in various forms of hypertensive disease (for review see Carretero & Scicli, 1978) , and these enzymes may be important in the control of blood pressure. Recent studies by Overlack, Stumpe, Zywzock, Ressel & Kruck (1979) demonstrated a hypotensive effect of pancreatic kallikrein administered orally to hypertensive patients. The purpose of the investigations summarized in this communication was to identify the kallikrein-containing cells in the various organs, and thus obtain some indication as to the mechanisms involved in the physiology of the kallikreinkinin system.
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Materials and methods
The cellular localization of glandular kallikreins was studied by direct immunoflurorescence (Brandtzaeg, 1973a,b) in exocrine organs of the rat and human. In the rat (Wistar rats, aged about 4 months), the organs were fixed in vim by ethanol (96%) perfusion through an artery close to the submandibular, sublingual or parotid salivary glands, the exorbital lacrimal gland, the pancreas or the kidney. Human tissue biopsies were obtained during surgery from the submandibular and parotid salivary glands and the pancreas, and as needle biopsies from the human kidney. The tissue was immediately placed in 96% ethanol for fixation, brought through xylene, and embedded in paraffin wax (Sainte-Marie, 1962) .
Tissue sections were incubated with tetramethylrhodamine isothiocyanate (MRITC) conjugates prepared from the immunoglobulin (1g)G fractions of antisera raised against purified kallikrein. For the rat tissues a sheep antiserum to rat urinary kallikrein and a rabbit antiserum to rat submandibular gland kallikrein were used. For the human tissues a rabbit antiserum to human urinary kallikrein was used. The absorbance ratios (,4280/,45,5) of the three conjugates were 2.6, 2.4 and 2-6 respectively, and their working concentrations were 0.5-0.7, 0.4-0.5 and 0.2-0.3 g of IgG/I, as established by performance testing on sections from each organ. The kidney tissue sections were pretreated with urea solution (6 mol/l, pH 3-2) for 30 min at room temperature (Brandtzaeg & Berdal, 1975) .
The immunological specificity of the immunohistochemical reaction with rat kallikrein was controlled by absorbing the conjugates with purified rat urinary kallikrein (Nustad & Pierce, 239s 240s T. B. 0rstavik. K . Nustad and P. Brandtzaeg 1974) or purified rat submandibular gland kallikrein, esterase A or esterase B (Brandtzaeg, Gautvik, Nustad & Pierce, 1976) . The reaction with human kallikrein was controlled by absorption with human urinary kallikrein and salivary fraction obtained by NH,(SO,), precipitation (50% saturation) of human whole saliva. This fraction was devoid of kallikrein but contained an antigen to which our antiserum showed contaminating activity.
Adjacent sections stained with haematoxylin and eosin or with the modified trichrome stain (McManus & Mowry, 1960) were used for morphological orientation.
Results
The specificity of the immunofluorescence reactions was verified by the absorption controls. Absorption of the conjugates with purified kallikrein inhibited the staining, whereas comparable absorptions with immunoreactive substances devoid of kallikrein did not.
There was complete agreement between the localization of kallikrein in rat and human tissues. In the major salivary glands, kallikrein was found in the duct system and was absent from the acinar cells. Kallikrein-specific staining was seen as a luminal rim in the striated duct cells. This luminal rim was intense in the intralobular striated ducts and seemed to indicate the presence of cytoplasmic kallikrein. Following the duct towards the gland hilus, the luminal rim became less intense. In the main excretory ducts, it was very faint, and cytoplasmic fluorescence was not observed in these cells. Kallikrein was not ,found in the intercalated ducts in any of the glands. In the rat submandibular gland, most of the kallikrein was present in the granular portion of the granular tubular cells. The other rat salivary and all human salivary glands lacked these specialized cells. The extremely large amounts of kallikrein in the rat submandibular gland could be ascribed to the granular tubular cells.
In the rat kidney, kallikrein was found in the distal tubular cells in the segment from the juxtaglomerular apparatus to the collecting duct. The distal tubular cells of the macula densa in the juxtaglomerular apparatus were kallikrein-negative, and the kallikrein-containing cells were seen first after the tubule had left the juxtaglomerular apparatus. Kallikrein was seen in distal tubules passing the juxtaglomerular apparatus of cortical glomeruli as well as of glomeruli lying in a juxtamedullary position. Kallikrein was not detected in the kidney medulla. Attempts to localize kallikrein in human kidney tissue obtained by needle biopsies were unsuccessful. In the rat and human pancreas, kallikrein was found in the granular portion of the acinar cells. Kallikrein was not seen in the ductal cells. However, in the rat pancreas, which was fixed by perfusion in vivo, a luminal rim was observed, probably representing secreted enzyme adhering to the duct wall. The islets of Langerhans were found to be kallikrein-negative in both species. Analyses of rat pancreatic extracts have shown that the kallikrein in this organ is a pro-enzyme (Orstavik & Glenner, 1978) . The acinar and duct cells of the rat exorbital lacrimal gland did not contain kallikrein. This agrees with the absence of Bz-Arg-OEt-esterase activity in gland homogenates and rat tears.
Discussion
The localization of glandular kallikreins in human tissue agreed with the localization of kallikrein as demonstrated in the rat (Orstavik, Nustad, Brandtzaeg & Halvorsen, 1975 Orstavik, 1978) , in the cat (Hojima, Maranda, Moriwaki & Schachter, 1977) , in the pig (Dietl, Kruck & Fritz, 1978) and in the guinea pig (Schachter, Maranda & Moriwaki, 1978) . Immunohistochemical localization of urinary kallikrein has been achieved only in the rat (Orstavik et al., 1976) , but a similar distribution of urinary kallikrein in the dog has been indicated by stop-flow studies (Scicli, Carretero, Hampton, Cortes & Oza, 1976) . The unsuccessful attempts to localize kallikrein in the human kidney should probably be ascribed to technical difficulties since glandular kallikrein is present in human urine. Thus fixation in vivo was crucial for the immunofluorescence demonstration of rat renal kallikrein. In addition, the human kidney contains smaller amounts of kallikrein than the rat kidney. Since the localization of glandular kallikreins in other organs has been shown to be the same in all species investigated, it seems reasonable to assume that this will also hold true for the kidney.
In the major salivary glands and the kidney, kallikrein is present in cells that are active in the secretion of electrolytes. In the pancreas, kallikrein is found exclusively as a pro-enzyme, and pancreatic kallikrein may have an extraglandular Localization of glandular kallikrein 241s function. Also in other kallikrein-containing glands, for example the toad skin and bladder (Chao & Margolius, 1978) and the human sweat glands (Fraki, Jansen & Hopsu-Havu, 1970) , cells resembling the striated duct cells of the salivary glands and the renal distal tubular cells are found. It is therefore possible that the function of kallikrein is important for processes taking place in such cells. In addition, a vasodiiatory effect through the formation of kinins seems possible since the salivary gland ducts and the renal distal tubules are closely surrounded by blood vessels. It has been suggested that kallikrein in the kidney is an important activator of prorenin (Sealey, Atlas & Laragh, 1978) . From an anatomical point of view such a relationship between the kalliikrein-kmin and the renin-angiotensin systems cannot be excluded. Prorenin is released into the afferent arteriole and may on its passage through the postglomerular capillaries come in contact with kallikrein. Some studies have indicated that glandular kallikrein enters the vascular compartment (Moriya, Moriwaki & Akimoto, 1967; Roblero, Croxatto, Garcia, Orstavik, Gautvik, 1978) . Corthorn & de Vito, 1976; Nustad & Hedemark-Poulsen, 
